BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6769270)

  • 1. A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test.
    Genazzani AR; Camanni F; Massara F; Picciolini E; Cocchi D; Belforte L; Müller EE
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):139-48. PubMed ID: 6769270
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
    Venturini PL; Alibrandi MP; Costantini S; Gaggero G; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):295-7. PubMed ID: 6803505
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic and therapeutic problems of hyper-prolactinemia in women.
    Flamigni C; Jasonni VM; Fuschini C; Bulletti C; Montevecchi P; Ferraretti AP
    Acta Eur Fertil; 1980 Dec; 11(4):247-58. PubMed ID: 6784429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of various hyperprolactin states in the clinical picture of infertility using functional tests].
    Pshenichnikova TIa; Ovsiannikova TV; Ioseliani MP; Afonina LI
    Akush Ginekol (Mosk); 1984 Feb; (2):21-5. PubMed ID: 6426333
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiologic and pathologic profiles of circulating human prolactin.
    Jaffe RB; Yuen BH; Keye WR; Midgley AR
    Am J Obstet Gynecol; 1973 Nov; 117(6):757-73. PubMed ID: 4200810
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
    Seki K; Uesato T; Kato K
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN; Tabor A
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum prolactin levels in amenorrhoea.
    Seppălă M; Hibroven E; Ranta T; Virkkunen P; Leppăluoto J
    Br Med J; 1975 May; 2(5966):305-6. PubMed ID: 1093605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrinological analysis of pituitary adenomas associated with hyperprolactinemia (author's transl)].
    Sato O; Hotta H; Nakagawa T; Sohma F; Hasunuma M; Tsuchita H; Tanabe S; Kobayashi K; Inoue Y
    No To Shinkei; 1981 Nov; 33(11):1115-23. PubMed ID: 6277351
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol Suppl (Copenh); 1978; 216():147-64. PubMed ID: 347859
    [No Abstract]   [Full Text] [Related]  

  • 13. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
    D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S
    Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary microadenoma and hyperprolactinemia: a cause of unexplained secondary amenorrhea.
    Boyar RM; Kapen S; Weitzman ED; Hellman L
    N Engl J Med; 1976 Jan; 294(5):263-5. PubMed ID: 811989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolactin and luteal phase defect (author's transl)].
    Mühlenstedt D; Meissner M; Schneider HP
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):580-7. PubMed ID: 467952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocrine diagnosis of pituitary adenomas (author's transl)].
    Nakai Y; Oki S; Nakao K; Fukada J; Kinoshita F; Tanaka K; Tsukada T; Imura H
    No To Shinkei; 1981 May; 33(5):431-40. PubMed ID: 6266437
    [No Abstract]   [Full Text] [Related]  

  • 18. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.